STOCKSCREENR
Log In

IBO.V

TSXV

Universal Ibogaine Inc.

$0.01-0.01(-50.00%)Mkt Cap: $1.56M

Key Stats

Market Cap

$1.56M

P/E Ratio

-0.25

EPS

$-0.02

Dividend Yield

0.00%

52-Week Range

$0.01 — $0.04

Volume

1.66M

Avg Volume

424.74K

Beta

—

Valuation

P/E (TTM)

-0.25

Forward P/E

—

PEG Ratio

0.21

P/S (TTM)

1.46

P/B (TTM)

5.67

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-1.21%

ROA (TTM)

-0.09%

ROIC

—

Gross Margin

0.09%

Operating Margin

0.25%

Net Margin

—

Debt/Equity

9.45

Current Ratio

0.39

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.97%

EPS Growth (5Y)

-0.43%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

—

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.00

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

312.86M

Float

303.14M

Free Float %

96.89%

About

Sector

Healthcare

Industry

Biotechnology

Country

CA

Exchange

TSXV

IPO Date

2017-06-22

Employees

—

CEO

Nicholas Peter Karos

Index Membership

—

Website

https://universalibogaine.com

Universal Ibogaine Inc. (IBO.V) is a healthcare company in the biotechnology industry listed on the TSXV. With a market capitalization of $1.56M, a P/E ratio of -0.25, IBO.V is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IBO.V against other stocks using dozens of fundamental and technical filters.

Similar Stocks

APS.TO

Aptose Biosciences Inc.

$2.22

+0.00%

$5.67M

IMRN

Immuron Limited

$0.71

-0.28%

$4.57M

ASBP

Aspire Biopharma Holdings, Inc.

$0.66

-5.96%

$2.28M

BRTX

BioRestorative Therapies, Inc.

$0.26

+11.93%

$2.27M

CARM

Carisma Therapeutics, Inc.

$0.04

+0.53%

$1.58M

INM

InMed Pharmaceuticals Inc.

$0.82

-6.82%

$1.48M

Frequently Asked Questions

What is Universal Ibogaine Inc.'s P/E ratio?

Universal Ibogaine Inc. (IBO.V) has a trailing twelve-month (TTM) P/E ratio of -0.25. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Universal Ibogaine Inc. pay a dividend?

No, Universal Ibogaine Inc. (IBO.V) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Universal Ibogaine Inc.'s market cap?

Universal Ibogaine Inc. (IBO.V) has a market capitalization of $1.56 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.